Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06693622 · ClinicalTrials.gov registry record
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
A clinical trial of Barrett Esophagus and Gastro Esophageal Reflux Disease, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 556
- Enrollment target
- 1
- Study location
NCT06693622 is a study of Barrett Esophagus and Gastro Esophageal Reflux Disease that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 556 participants, below the 3,548-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06693622, a study of Barrett Esophagus and Gastro Esophageal Reflux Disease, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 556 participants
- Enrollment target
- 1
- Study location
Study Summary
This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of people who die from esophageal cancer.
Conditions Studied
Interventions
- BEHAVIORAL Patient survey
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 556 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2029-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06693622
The ClinicalTrials.gov registry entry for NCT06693622 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 556 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,548-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (84% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which Patient survey is the first listed.
NCT06693622 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT06693622 about?
NCT06693622 is a clinical study titled "Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests". This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decr...
What is the current status of trial NCT06693622?
This trial is currently recruiting. The enrollment target is 556 participants. The study started on 2024-11-01. Estimated completion is 2029-03-01.
What conditions does trial NCT06693622 study?
This clinical trial studies the following conditions: Barrett Esophagus, Gastro Esophageal Reflux Disease.
What interventions are being tested in trial NCT06693622?
The interventions under investigation include: Patient survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT06693622?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06693622 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
-
Longitudinal Oral Microbiome Sampling for BE
RECRUITING
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.